News & Observer | newsobserver.com | Stem cell research

Published: Dec 10, 2006 12:00 AM
Modified: Dec 10, 2006 08:24 AM

Stem cell research

 

Story Tools

Advertisements
President Bush used the only veto of his presidency so far to reject a bill passed by Congress last year that would have expanded embryonic stem cell research through government funding.

Supporters of such research say it could lead to treatments and cures for a wide variety of ailments, including Alzheimer's and Parkinson's diseases as well as spinal cord injuries. Bush and abortion foes, however, have opposed expanding embryonic stem cell research because the embryos die in the process of harvesting the stem cells from them.

Senate Majority Leader-elect Harry Reid said he hopes that the president will relent and that some Republicans will now join Democrats on the side of expanded research.

the Associated Press

All rights reserved. This copyrighted material may not be published, broadcast or redistributed in any manner.

Get $150+ in coupons in every Sunday N&O. Click here for convenient home delivery.

No comments have been posted for this story. Log in to be the first to comment.
 

 

The News & Observer is pleased to be able to offer its users the opportunity to make comments and hold conversations online. However, the interactive nature of the internet makes it impracticable for our staff to monitor each and every posting.

Since The News & Observer does not control user submitted statements, we cannot promise that readers will not occasionally find offensive or inaccurate comments posted on our website. In addition, we remind anyone interested in making an online comment that responsibility for statements posted lies with the person submitting the comment, not The News and Observer.

If you find a comment offensive, clicking on the exclamation icon will flag the comment for review by the administrators, we are counting on the good judgment of all our readers to help us.

Hosting Partners of
newsobserver.com

A subsidiary of The McClatchy Company